Sale!

Mounjaro 5mg Injection

Manufacturer: Eli Lilly & Company India Pvt Ltd
Combination: Tirzepatide

4.5 (154)

Original price was: ₹4,102.Current price is: ₹3,650.

1 Vial of 0.5ml

Mounjaro 5mg Injection contains Tirzepatide, a dual GIP and GLP-1 receptor agonist used for type 2 diabetes management. It is taken once a week and helps with weight loss and blood sugar control.

People who have a personal or family history of MEN2 or medullary thyroid cancer (MTC) are not advised to use this injection. Because it could harm the unborn child, pregnant women should avoid it. They should also talk to their doctor about any prescription interactions.

This product is non-returnable.

Description

Mounjaro 5mg Injection contains Tirzepatide, a dual GIP and GLP-1 receptor agonist used for type 2 diabetes management. It is taken once a week and helps with weight loss and blood sugar control.

Brand Name: Mounjaro

Composition: Tirzepatide

Mechanism of Action:

A dual GIP and GLP-1 receptor agonist, tirzepatide aids in controlling blood sugar levels in people with type 2 diabetes. It functions by slowing stomach emptying, which raises satiety and may aid in weight loss, decreasing glucagon levels to lower blood sugar, and increasing insulin production in response to meal consumption.

Uses:
  • Type-2 Diabetes Mellitus
  • Weight Management
Dosage and Administration:

Given once a week as a subcutaneous injection. Depending on tolerance and individual response, the dosage may be changed.

Side Effects:
  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Decreased appetite
  • Injection site reactions (Itching, Rashes)
  • Hypoglycemia
Safety Advise:

Lungs
The safety of Mounjaro Injection for individuals with lung issues is uncertain. Kindly speak with your healthcare provider.

Liver
The safety of Mounjaro Injection for individuals with liver issues is uncertain. Kindly speak with your healthcare provider.

Kidney
The safety of Mounjaro Injection for individuals with Kidney issues is uncertain. Kindly speak with your healthcare provider.

Pregnancy
Mounjaro should be used during pregnancy only if clearly needed, Kindly speak with your healthcare provider.

Breast Feeding
Using Mounjaro while nursing is most likely dangerous. Kindly speak with your healthcare provider.

Storage:

Store Mounjaro 5mg Injection in a refrigerator (2°C to 8°C), do not freeze up, protect from sunlight, and use within 21 days if kept at room temperature (up to 30°C).

How to use this Medication?

This drug is administered subcutaneously. You’ll learn how to prepare and administer it. It is administered once every seven days, or once a week. Unless instructed otherwise by your healthcare provider, continue taking it.

You should inject this medication and insulin separately if you take both together. Don’t combine them. Avoid administering the shots directly close to one another. With every injection, rotate the injection sites.

References:

1. Baker DE, Walley K, Levien TL. Tirzepatide. Hospital Pharmacy. 2023 Jun;58(3):227-43.

2. Karagiannis T, Avgerinos I, Liakos A, Del Prato S, Matthews DR, Tsapas A, Bekiari E. Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis. Diabetologia. 2022 Aug;65(8):1251-61.

3. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022 Jul 21;387(3):205-16.

4. Chavda VP, Ajabiya J, Teli D, Bojarska J, Apostolopoulos V. Tirzepatide, a new era of dual-targeted treatment for diabetes and obesity: a mini-review. Molecules. 2022 Jul 5;27(13):4315.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website’s contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Eli Lilly and Company India Pvt Ltd

Address: Plot# 92, Sector 32, Institutional Area, Gurgaon-122001, HARYANA, INDIA

Country of origin: United states

Medical Disclaimer:

Mounjaro 5mg Injection is a prescription-only medicine and must be used strictly under the supervision and guidance of a qualified healthcare professional. Do not self-medicate, alter the dosage, or discontinue use without consulting your doctor. The information provided here is for educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Individual results, benefits, and risks may vary. Always consult your physician before starting, changing, or stopping any medication.

Contact Us

Category
Info Table
Vendor Info
Benefits
Reviews

Description

Mounjaro 5mg Injection contains Tirzepatide, a dual GIP and GLP-1 receptor agonist used for type 2 diabetes management. It is taken once a week and helps with weight loss and blood sugar control.

Brand Name: Mounjaro

Composition: Tirzepatide

Mechanism of Action:

A dual GIP and GLP-1 receptor agonist, tirzepatide aids in controlling blood sugar levels in people with type 2 diabetes. It functions by slowing stomach emptying, which raises satiety and may aid in weight loss, decreasing glucagon levels to lower blood sugar, and increasing insulin production in response to meal consumption.

Uses:
  • Type-2 Diabetes Mellitus
  • Weight Management
Dosage and Administration:

Given once a week as a subcutaneous injection. Depending on tolerance and individual response, the dosage may be changed.

Side Effects:
  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Decreased appetite
  • Injection site reactions (Itching, Rashes)
  • Hypoglycemia
Safety Advise:

Lungs
The safety of Mounjaro Injection for individuals with lung issues is uncertain. Kindly speak with your healthcare provider.

Liver
The safety of Mounjaro Injection for individuals with liver issues is uncertain. Kindly speak with your healthcare provider.

Kidney
The safety of Mounjaro Injection for individuals with Kidney issues is uncertain. Kindly speak with your healthcare provider.

Pregnancy
Mounjaro should be used during pregnancy only if clearly needed, Kindly speak with your healthcare provider.

Breast Feeding
Using Mounjaro while nursing is most likely dangerous. Kindly speak with your healthcare provider.

Storage:

Store Mounjaro 5mg Injection in a refrigerator (2°C to 8°C), do not freeze up, protect from sunlight, and use within 21 days if kept at room temperature (up to 30°C).

How to use this Medication?

This drug is administered subcutaneously. You’ll learn how to prepare and administer it. It is administered once every seven days, or once a week. Unless instructed otherwise by your healthcare provider, continue taking it.

You should inject this medication and insulin separately if you take both together. Don’t combine them. Avoid administering the shots directly close to one another. With every injection, rotate the injection sites.

References:

1. Baker DE, Walley K, Levien TL. Tirzepatide. Hospital Pharmacy. 2023 Jun;58(3):227-43.

2. Karagiannis T, Avgerinos I, Liakos A, Del Prato S, Matthews DR, Tsapas A, Bekiari E. Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis. Diabetologia. 2022 Aug;65(8):1251-61.

3. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022 Jul 21;387(3):205-16.

4. Chavda VP, Ajabiya J, Teli D, Bojarska J, Apostolopoulos V. Tirzepatide, a new era of dual-targeted treatment for diabetes and obesity: a mini-review. Molecules. 2022 Jul 5;27(13):4315.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website’s contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Eli Lilly and Company India Pvt Ltd

Address: Plot# 92, Sector 32, Institutional Area, Gurgaon-122001, HARYANA, INDIA

Country of origin: United states

Medical Disclaimer:

Mounjaro 5mg Injection is a prescription-only medicine and must be used strictly under the supervision and guidance of a qualified healthcare professional. Do not self-medicate, alter the dosage, or discontinue use without consulting your doctor. The information provided here is for educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Individual results, benefits, and risks may vary. Always consult your physician before starting, changing, or stopping any medication.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Mounjaro 5mg Injection”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Mounjaro 5mg Injection used for?
Mounjaro 5mg Injection (Tirzepatide) is prescribed for the management of Type 2 diabetes and may help control blood sugar levels. It may also be associated with weight reduction in some patients by reducing appetite and slowing digestion. However, individual outcomes may vary, and it should only be used as directed by your doctor.
Mounjaro is intended to be administered as a subcutaneous injection once weekly (under the skin). It is generally recommended to be taken on the same day each week, as prescribed by your doctor. Do not alter the schedule without medical guidance.
Treatment typically begins at 2.5mg once weekly and may be gradually increased to 5mg or higher, depending on the patient’s response and tolerability. Dose adjustments should only be made under the supervision of a qualified healthcare professional.
Some clinical studies have suggested that Mounjaro may be associated with weight reduction in certain patients, potentially through appetite suppression and reduced calorie intake. However, weight loss is not guaranteed and may vary significantly between individuals. It is not approved solely as a weight-loss drug in all regions. Please consult your physician to understand whether this benefit may apply to your situation.
Mounjaro may be used alongside certain other antidiabetic medications, but caution is advised when combining it with insulin or insulin secretagogues, as this may increase the risk of low blood sugar (hypoglycaemia) in some patients. Your doctor will assess the most appropriate combination for your condition.
No. Mounjaro is a prescription-only medicine and must be obtained and used only under the guidance of a qualified and licensed healthcare professional.

Related products

Manufacturer: Eli Lilly & Company India Pvt Ltd
Combination: Tirzepatide

Manufacturer: Eli Lilly & Company India Pvt Ltd
Combination: Tirzepatide

Manufacturer: Eli Lilly & Company India Pvt Ltd
Combination: Tirzepatide

Manufacturer: Eli Lilly & Company India Pvt Ltd
Combination: Tirzepatide